Company intelligence / Profile preview

DynoSense

San Jose, California, United States

Ownership: Private
Development stage: Other

Overview

DynoSense received FDA clearance for its Vital Signs Measuring System, which captures electrocardiogram, respiration rate, body temperature, oxygen saturation, pulse rate, and heart rate, with cloud-based analytics and intelligent alerts for clinical interpretation

Therapeutic areas: Women's HealthOther
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Advent Holdings Inc. (Hong Kong and Macau distribution, 2020)JKOM Cloud Health Technology Co. (China marketing and distribution)

Beyond the preview

Go deeper on DynoSense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DynoSense.

Explore the full profile